The most telling story at TRMD A this week is not the 2.5% price gain or the easing borrow market. It is the simultaneous, opposing moves by the company's two most senior executives.
The CEO bought, the CFO sold, and the divergence is worth unpacking. On September 24, CEO Jacob Balslev Meldgaard exercised options and took on 85,067 shares at an effective price of $27.34, a transaction valued at roughly $2.3 million. That followed an exercise-and-hold at a similar scale back in May. The CFO, Kim Balle, did the opposite: he sold a total of 42,533 shares across three sessions between September 18 and September 22, realising roughly $1.6 million in proceeds. Neither trade was made under a pre-arranged 10b5-1 plan. Net insider activity over the past 90 days runs to roughly negative 42,000 shares and a net outflow of about $1.6 million, so the selling edge holds in aggregate, but the CEO's discretionary buy into a rising tape is not a signal to dismiss.
The borrow market offers no drama. Availability is extremely loose, with nearly 20 times as many shares available to borrow as are currently lent out. That figure has nearly doubled in a week, moving from around 1,250% to 1,957%. Borrow costs have fallen roughly 17% on the week to about 1.56%, and the trend has been down from a mid-September peak near 2.7%. The ORTEX short score has also eased, dropping from a recent high of 38.4 on September 25 to 33.1 by Tuesday, its lowest reading in the window. Taken together, the lending market is moving away from any squeeze tension, and short sellers are not pressing.
The activist register adds another layer of complexity. Hafnia Limited, the Oslo-listed product tanker company, sits as a 13D filer with a 19.85% stake in TORM, last updated on September 25. A related vehicle, OCM Njord Holdings, has been steadily trimming: its stake has fallen from 23.39% to 19.86% on one filing series, and from 11.06% to 6.17% on a more recent amendment filed September 24. The aggregate picture is one of a major strategic holder that has been reducing its position in measured steps. As the disclosure note makes clear, stakes are reported around the 5% threshold and positions can fall below that level without a further filing, so the current OCM Njord holding of 6.17% warrants watching closely for any further amendments. Hafnia's own position, by contrast, edged higher, from 18.22% to 19.85%.
Valuation looks undemanding relative to earnings. The trailing price-to-earnings ratio is close to 6x, and EV/EBITDA has compressed by about 0.65 turns over the past month even as the stock has risen 15% in that period. The price-to-book ratio has moved up to roughly 1.47x, adding about 0.11 turns over 30 days. Factor scores flag genuine strengths: 30-day EPS momentum ranks in the 95th percentile and the dividend score registers 93, suggesting the market is still pricing in meaningful cash returns. The days-to-cover rank of 79 reflects the ease of the borrow rather than any speculative edge. Analyst data on file is more than three years old and should not be used to frame a price target.
On earnings, the next print is scheduled for November 4. The two most recent results produced minimal next-day moves, a fall of under 1% after August's release, and a more notable 4% drop following the May quarter. The five-day window after August's results, however, saw the stock recover and add 5.5%. Close peer HAFNI gained 4.4% on the day and is up 2.9% on the week, broadly in line with TORM. INSW outpaced the group, adding 6.1% over the same period.
The November 4 print will arrive with the CEO having just added to his stake and the CFO having trimmed. Whether that gap in conviction narrows or widens before then is worth watching.
See the live data behind this article on ORTEX.
Open TRMD A on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
